(Q46061241)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Marianna Mazza

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

G Martinotti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

D Tedeschi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

S Andreoli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

D Reina

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

M Pomponi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

R Romanelli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

N Moroni

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

R De Filippis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

M Di Giannantonio

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

G Pozzi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

P Bria

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

L Janiri

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

language of work or name

English

0 references

publication date

3 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychopharmacology

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

1367-1374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

How many cravings? Pharmacological aspects of craving treatment in alcohol addiction: a review.

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Novel anticonvulsants in the treatment of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

3-substituted GABA analogs with central nervous system activity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Patients with schizophrenia treated with aripiprazole, a multicentre naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Review: acamprosate and naltrexone are safe and effective but have low compliance rates for people with alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Long-term efficacy of pregabalin in generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Reduction in heavy drinking as a treatment outcome in alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

The Italian version of the Obsessive-Compulsive Drinking Scale: validation, comparison with the other versions, and difference between type 1- and type 2-like alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Topiramate for treating alcohol dependence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Individual differences predictive of drinking to manage anxiety among non-problem drinkers with panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

The relation between alcohol problems and the anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Benzodiazepine treatment for alcohol-dependent patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Block by gabapentin of the facilitation of glutamate release from rat trigeminal nucleus following activation of protein kinase C or adenylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Efficacy and safety of pregabalin in alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Pregabalin in generalized anxiety disorder: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

A rational approach to the pharmacotherapy of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Pharmacokinetics of pregabalin in subjects with various degrees of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Pregabalin in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Measuring the quality of life of cancer patients: a concise QL-index for use by physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102623

21 January 2018

Identifiers

DOI

10.1177/0269881109102623

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346279%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference